Table 2. Adverse events in >1 retreated patient overall, by age group.

	Incidence in retreatment, n (%)
	Adult (n=9)	Children and Adolescents (n=2)	All (N=11)
Any adverse event	9 (100)	1 (50)	10 (91)
Pyrexia	7 (78)	1 (50)	8 (73)
Diarrhea	3 (33)	1 (50)	4 (36)
Leukopenia	3 (33)	0 (0)	3 (27)
Neutropenia	3 (33)	0 (0)	3 (27)
Thrombocytopenia	3 (33)	0 (0)	3 (27)
Anemia	2 (22)	0 (0)	2 (18)
Cough	2 (22)	0 (0)	2 (18)
Epistaxis	1 (11)	1 (50)	2 (18)
Fatigue	2 (22)	0 (0)	2 (18)
Febrile neutropenia	1 (11)	1 (50)	2 (18)
Muscular weakness	2 (22)	0 (0)	2 (18)
Myopathy	2 (22)	0 (0)	2 (18)
Edema	2 (22)	0 (0)	2 (18)
Paresthesia	2 (22)	0 (0)	2 (18)
Tachycardia	2 (22)	0 (0)	2 (18)
Weight decreased	2 (22)	0 (0)	2 (18)
Weight increased	2 (22)	0 (0)	2 (18)
Any adverse event grade ⩾3	7 (78)	1 (50)	8 (73)
Neutropenia	3 (33)	0 (0)	3 (27)
Thrombocytopenia	3 (33)	0 (0)	3 (27)
Anemia	2 (22)	0 (0)	2 (18)
Febrile neutropenia	1 (11)	1 (50)	2 (18)